Synchrony Financial (SYF) Goldman Sachs 2024 U.S. Financial Services Conference summary

Regulatory and macroeconomic environment

• Anticipates potential for a lighter regulatory environment in 2025, which could benefit operations, but awaits clarity before making changes.

• Recent court developments on late fees are viewed positively, with ongoing litigation being closely monitored.

• No immediate changes planned to pricing actions; any future adjustments will be made collaboratively with partners once regulatory certainty is achieved.

• Renewals and new contracts now include scenario-based clauses to address regulatory changes, especially regarding late fees.

• Monitoring long-term debt rule and Basel III, with focus on proactive regulatory engagement.

Credit performance and consumer trends

• Consumer resilience has exceeded expectations, with credit metrics stabilizing and performing in line with forecasts.

• Underwriting tightened in 2023 and 2024, especially for non-prime and certain risk factors, leading to lower new accounts and purchase volume.

• Delinquencies have outperformed seasonality for several months, though loss rates remain elevated due to higher balances in delinquency.

• Loss rates are expected to trend back toward target range as the impact of prior credit expansion is digested.

• Allowance levels are expected to decline as confidence in the economic outlook improves.

Business growth, investments, and partner strategy

• Significant investment in a comprehensive product suite, digital integration, and advanced underwriting (PRISM) to differentiate and support partners.

• Health and wellness platform remains the strongest growth area, with high account and loan growth, strong customer satisfaction, and a large addressable market.

• Business development pipeline is robust, focusing on alignment of interests and risk-adjusted returns in new and renewed partnerships.

• Recent renewals and new partner launches have included scenario planning for regulatory changes and often involve technology or value proposition enhancements.

• Organic growth remains the top capital allocation priority, with disciplined approach to M&A and continued share repurchases.